Sign in Subscribe
Diseases

Sugar-Sweetened Beverage Consumption Linked to Fatty Liver Disease in Type 2 Diabetes Patients

Strategic Insights

— 1 min read

Research has identified a significant link between sugar-sweetened beverage (SSB) consumption and the risk of developing metabolic associated fatty liver disease (MAFLD) in patients with type 2 diabetes mellitus (T2DM). A study published in Frontiers in Endocrinology found that individuals with T2DM who consumed SSBs had a higher risk of developing MAFLD compared to those who did not consume SSBs.

Key Takeaways:

  • The study, conducted by researchers at Taizhou Central Hospital (Taizhou University Hospital), involved 3,305 patients with T2DM, who were classified into MAFLD and non-MAFLD groups based on liver ultrasonography.
  • The results showed that MAFLD patients had significantly higher body mass index (BMI), waist-to-hip ratios, and SSB consumption compared to non-MAFLD patients (p-value < 0.001).
  • The study found that SSB consumption independently predicted MAFLD risk in T2DM patients, with synergistic effects from dysregulated glycometabolism.
  • The Multi-Marker-Based Glycometabolic (MMBG) model, which incorporates SSB consumption and glycometabolic parameters, was identified as a robust tool for early MAFLD risk identification and personalized interventions.

Statistics:

  • 3,305 patients with type 2 diabetes mellitus were enrolled in the study.
  • MAFLD patients had a significantly higher BMI (30.2 ± 3.5 kg/m²) compared to non-MAFLD patients (24.5 ± 2.8 kg/m²).
  • SSB consumption was significantly higher in MAFLD patients (12.1 ± 2.5 SSBs/week) compared to non-MAFLD patients (5.6 ± 1.8 SSBs/week).
  • The MMBG model showed a high sensitivity (93.4%) and specificity (84.2%) for predicting MAFLD risk in T2DM patients.

Sources:

  • "Sugar-sweetened beverage consumption predicts metabolic associated fatty liver disease in patients with type 2 diabetes mellitus." Frontiers in Endocrinology, 2025,16. (Frontiers in Endocrinology - http://www.frontiersin.org/endocrinology).
  • Data used in this report was obtained from a new study published in Frontiers in Endocrinology.
  • NewsRx. Studies from Taizhou Central Hospital (Taizhou University Hospital) Yield New Data on Fatty Liver Disease (Sugar-sweetened beverage consumption predicts metabolic associated fatty liver disease in patients with type 2 diabetes mellitus). Obesity & Diabetes Week. October 13, 2025; p 163.

Read more